IL-6 Induces Treg Dysfunction in Desiccating Stress-induced Dry Eye Disease

Overview

Journal Exp Eye Res

Specialty Ophthalmology

Date 2024 Jul 15

PMID 39009059

Authors

Gustavo Ortiz

Tomas Blanco

Rohan Bir Singh

Francesca Kahale

Shudan Wang

Yihe Chen

Reza Dana

Affiliations

Soon will be listed here.

Abstract

Regulatory T cells (Tregs) play a critical role in maintaining immune homeostasis, and their dysfunction is implicated in the pathogenesis of various autoimmune disorders, including dry eye disease (DED). Treg dysfunction in DED allows T-helper cell 17 (Th17) mediated chronic inflammation at the ocular surface. In this study, the factors causing Treg dysfunction in DED were investigated. We observed reduced expression of Treg functional markers - FoxP3, CD25, and CTLA-4 in the cells isolated from DED mice (DED Tregs). Additionally, DED Tregs showed increased expression levels of receptors for pro-inflammatory cytokine receptors, namely IL-6R, IL-17RA, and IL-23R. An increased expression level of pro-inflammatory cytokine receptors was observed on exposing Tregs isolated from naïve mice (NTregs) to IL-6 or IL-17, but not IL-23, with a concomitant downregulation of FoxP3, CD25, and CTLA-4 in these cells. Furthermore, among these cytokines, IL-6 induced the most pronounced loss of Treg mediated suppression of Th17 proliferation and IL-10 secretion. In vitro and in vivo blockade of IL-6 effectively restored function in DED Tregs, leading to enhanced suppressive function against proliferating Th17 cells and ameliorating disease severity. In conclusion, this study provides insights into mechanisms of Treg dysregulation in DED, specifically delineating the effect of Th17-associated cytokines, with IL-6 emerging as the critical factor inducing Treg dysfunctionality. These findings highlight the potential for developing novel therapeutic interventions for DED through restoration of immunosuppressive function of Tregs.

References

Jin Y, Chauhan S, Saban D, Dana R . Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. Invest Ophthalmol Vis Sci. 2009; 51(2):816-21. PMC: 2868459. DOI: 10.1167/iovs.09-3952. View

Ma B, Zhou Y, Liu R, Zhang K, Yang T, Hu C . Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf. 2021; 20:70-85. DOI: 10.1016/j.jtos.2020.12.007. View

Luo L, Li D, Doshi A, Farley W, Corrales R, Pflugfelder S . Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci. 2004; 45(12):4293-301. DOI: 10.1167/iovs.03-1145. View

Yoon K, Jeong I, Park Y, Yang S . Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007; 26(4):431-7. DOI: 10.1097/ICO.0b013e31803dcda2. View

Stevenson W, Chauhan S, Dana R . Dry eye disease: an immune-mediated ocular surface disorder. Arch Ophthalmol. 2012; 130(1):90-100. PMC: 3677724. DOI: 10.1001/archophthalmol.2011.364. View

Shao C, Chen Y, Nakao T, Amouzegar A, Yin J, Tahvildari M . Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival. Transplantation. 2018; 103(1):182-190. PMC: 6309927. DOI: 10.1097/TP.0000000000002442. View

Roda M, Corazza I, Bacchi Reggiani M, Pellegrini M, Taroni L, Giannaccare G . Dry Eye Disease and Tear Cytokine Levels-A Meta-Analysis. Int J Mol Sci. 2020; 21(9). PMC: 7246678. DOI: 10.3390/ijms21093111. View

Wolffsohn J, Wang M, Vidal-Rohr M, Menduni F, Dhallu S, Ipek T . Demographic and lifestyle risk factors of dry eye disease subtypes: A cross-sectional study. Ocul Surf. 2021; 21:58-63. DOI: 10.1016/j.jtos.2021.05.001. View

Chen Y, Chauhan S, Lee H, Saban D, Dana R . Chronic dry eye disease is principally mediated by effector memory Th17 cells. Mucosal Immunol. 2013; 7(1):38-45. PMC: 3732510. DOI: 10.1038/mi.2013.20. View

10.

Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana M . The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005; 46(8):2766-71. DOI: 10.1167/iovs.04-1326. View

11.

Yu M, Lee S, Lee H, Amouzegar A, Nakao T, Chen Y . Neurokinin-1 Receptor Antagonism Ameliorates Dry Eye Disease by Inhibiting Antigen-Presenting Cell Maturation and T Helper 17 Cell Activation. Am J Pathol. 2019; 190(1):125-133. PMC: 6943374. DOI: 10.1016/j.ajpath.2019.09.020. View

12.

Taketani Y, Marmalidou A, Dohlman T, Singh R, Amouzegar A, Chauhan S . Restoration of Regulatory T-Cell Function in Dry Eye Disease by Antagonizing Substance P/Neurokinin-1 Receptor. Am J Pathol. 2020; 190(9):1859-1866. PMC: 7456741. DOI: 10.1016/j.ajpath.2020.05.011. View

13.

Niederkorn J, Stern M, Pflugfelder S, de Paiva C, Corrales R, Gao J . Desiccating stress induces T cell-mediated Sjögren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006; 176(7):3950-7. DOI: 10.4049/jimmunol.176.7.3950. View

14.

Hua J, Inomata T, Chen Y, Foulsham W, Stevenson W, Shiang T . Pathological conversion of regulatory T cells is associated with loss of allotolerance. Sci Rep. 2018; 8(1):7059. PMC: 5935752. DOI: 10.1038/s41598-018-25384-x. View

15.

Dana R, Meunier J, Markowitz J, Joseph C, Siffel C . Patient-Reported Burden of Dry Eye Disease in the United States: Results of an Online Cross-Sectional Survey. Am J Ophthalmol. 2020; 216:7-17. DOI: 10.1016/j.ajo.2020.03.044. View

16.

Tsubota K, Pflugfelder S, Liu Z, Baudouin C, Kim H, Messmer E . Defining Dry Eye from a Clinical Perspective. Int J Mol Sci. 2020; 21(23). PMC: 7730816. DOI: 10.3390/ijms21239271. View

17.

Hua J, Stevenson W, Dohlman T, Inomata T, Tahvildari M, Calcagno N . Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis. Invest Ophthalmol Vis Sci. 2016; 57(3):1457-67. PMC: 4819620. DOI: 10.1167/iovs.15-17551. View

18.

. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):75-92. DOI: 10.1016/s1542-0124(12)70081-2. View

19.

Dienz O, Rincon M . The effects of IL-6 on CD4 T cell responses. Clin Immunol. 2008; 130(1):27-33. PMC: 2660866. DOI: 10.1016/j.clim.2008.08.018. View

20.

Siemasko K, Gao J, Calder V, Hanna R, Calonge M, Pflugfelder S . In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci. 2008; 49(12):5434-40. DOI: 10.1167/iovs.08-2075. View